Fuso Pharmaceutical Industries Ltd (4538) Stock Price & News

4538:TYO

Fuso Pharmaceutical Industries Ltd

¥2,165.00

-1.86%

(-41.00) 1D

Oct 2, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4538...

Open

¥2,192

High

¥2,192

Low

¥2,161

Mkt. cap

20.46B

Avg. vol.

13.68K

Volume

20.70K

Dividend

4.16%

Quarterly dividend

¥23

Ex-dividend date

Sep 29, 2026

P/E ratio

8.44

52-wk high

¥2,530

52-wk low

¥1,990

EPS

¥257

Shares outstanding

8.78M

No. of employees

Open

¥2,192

High

¥2,192

Low

¥2,161

Mkt. cap

20.46B

Avg. vol.

13.68K

Volume

20.70K

Dividend

4.16%

Quarterly dividend

¥23

Ex-dividend date

Sep 29, 2026

P/E ratio

8.44

52-wk high

¥2,530

52-wk low

¥1,990

EPS

¥257

Shares outstanding

8.78M

No. of employees

Related stocks

4552

JCR Pharmaceuticals Co Ltd

¥484.00

-3.59%

4521

Kaken Pharmaceutical Co Ltd

Zeria Pharmaceutical Co Ltd

¥1,898.00

-2.72%

News stories

From web sources and news partners

marketscreener.com

50 minutes ago

S&P holds Romania rating, expects credible budget framework

BigGo Finance

1 hour ago

U.S. 10-Year Yield Tops 5.3%: S&P 500 Looks Solid on the Surface, But Five Major Sectors Are Already Cracking

TradingView

1 hour ago

Nasdaq rises for the week as Lumentum leads gains

U.S. Global Investors

55 minutes ago

Gold Stumbled in September, but Gold Miners Beat Every Sector in the S&P 500

About Fuso Pharmaceutical Industries Ltd

CEO-

Employees1.37K

FoundedMar 25, 1937

Headquarters-

SectorPharmaceutical industry

Websitefuso-pharm.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	15.73B	17.04B	14.04B	16.05B
Cost of goods sold	11.70B	12.62B	10.57B	11.85B
Cost of revenue	11.70B	12.62B	10.57B	11.85B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.38B	3.30B	3.20B	3.22B
Operating expense	3.38B	3.30B	3.20B	3.22B
Total operating expenses	15.08B	15.91B	13.77B	15.07B
Operating income	650.00M	1.12B	272.00M	973.00M
Other non operating income	-110.00M	-24.00M	-40.00M	-134.00M
EBT including unusual items	456.00M	1.20B	132.00M	910.00M
EBT excluding unusual items	478.00M	1.08B	131.00M	828.00M
Income tax expense	87.00M	350.00M	-195.00M	268.00M
Effective tax rate	19.08%	29.09%	-147.73%	29.45%
Other operating expenses	-	-	-	-
Net income	369.00M	853.00M	327.00M	642.00M
Net profit margin	2.35%	5.01%	2.33%	4.00%
Earnings per share	-	-	-	-
Interest and investment income	14.00M	67.00M	1.00M	93.00M
Interest expense	-76.00M	-80.00M	-102.00M	-104.00M
Net interest expenses	-62.00M	-13.00M	-101.00M	-11.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	1.30B	-	926.50M	1.63B
Gain or loss from assets sale	-	-	-	-

Ask anything